KYNTRA BIO, INC. (KYNB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 60M 120M 180M Q3 '23: 155M Q4 '24: 29.6M Q1 '25: 7M Q2 '25: 7.3M Q3 '25: 8.3M Q4 '25: 6.4M Q1 '26: 7.4M Q2 '26: 4.6M Q3 '23 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 50M 100M 150M Q3 '22: 104.4M Q4 '22: 120.5M Q1 '23: 96.5M Q2 '23: 112.2M Q3 '23: 136.6M Q4 '25: 5.9M Q1 '26: 3M Q2 '26: 289K Q3 '22 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '25 Q1 '26 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-270M -180M -90M 0 90M 180M 270M Q3 '24: -238.4M Q4 '24: -150.4M Q1 '25: -116.2M Q2 '25: -81.8M Q3 '25: -39.5M Q4 '25: -45.9M Q1 '26: -44.8M Q2 '26: -50.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-160M -80M 0 80M 160M 240M Q3 '24: -121.8M Q4 '24: -47.6M Q1 '25: -10M Q2 '25: -2.1M Q3 '25: 215.7M Q4 '25: 183.5M Q1 '26: 163.6M Q2 '26: 183.2M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 7M 14M 21M Q3 '22: 18.5M Q4 '22: 20.3M Q1 '23: 19.5M Q2 '23: 18.4M Q3 '23: 18.4M Q4 '25: 557K Q1 '26: 4.4M Q2 '26: 4.3M Q3 '22 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

-450M -300M -150M 0 150M 300M 450M Q4 '23: -315M Q1 '24: -272.7M Q2 '24: -202M Q3 '24: -125.9M Q4 '24: -138M Q1 '25: -76M Q2 '25: -23.4M Q3 '25: -16.9M Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25

Free Cash Flow TTM

-450M -300M -150M 0 150M 300M 450M Q4 '23: -317.5M Q1 '24: -274.7M Q2 '24: -203M Q3 '24: -126.2M Q4 '24: -138.3M Q1 '25: -76.2M Q2 '25: -23.7M Q3 '25: -17.1M Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 35M 70M 105M Q1 '24: 99M Q2 '24: 4M Q3 '24: 4M Q1 '25: 4M Q2 '25: 4M Q3 '25: 4M Q1 '26: 4M Q2 '26: 4M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-20.00 0.00 20.00 40.00 60.00 Q3 '24: -9.04 Q4 '24: -11.89 Q1 '25: -10.41 Q2 '25: -8.40 Q3 '25: 45.46 Q4 '25: 45.37 Q1 '26: 40.46 Q2 '26: 45.30 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.